Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2017-05-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-017-4275-8PMID 28488140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH

  2016cited by this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015cited by this paper
• Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review

  2015cited by this paper
• A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations.

  2014cited by this paper
• Advanced tools for BRCA1/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection

  2014cited by this paper
• BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

  2011cited by this paper
• Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family

  2010cited by this paper
• Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation

  2010influential reference
• HERC2 is an E3 ligase that targets BRCA1 for degradation.

  2010cited by this paper
• Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

  2010cited by this paper
• Genomic rearrangements in BRCA1 and BRCA2: A literature review

  2009cited by this paper
• The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

  2006cited by this paper
• Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.

  2006cited by this paper
• Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations

  2006cited by this paper
• Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.

  2006cited by this paper
• Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

  2006cited by this paper
• Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

  2005cited by this paper
• The Genetic Epidemiology of Breast Cancer Genes

  2004cited by this paper
• Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

  2003cited by this paper
• Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

  2002cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer

  2000cited by this paper
• The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

  2000cited by this paper
• An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?

  1999cited by this paper
• Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.

  1996cited by this paper

• Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects

  2024cites this paper
• Targeting transposable elements in cancer: Developments and opportunities.

  2024cites this paper
• BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation

  2022cites this paper
• BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning.

  2022cites this paper
• The BRCA1 c.788G > T (NM_007294.4) variant in a high grade serous ovarian cancer (HGSOC) patient: foods for thought

  2021cites this paper
• To Build or To Break: The Dual Impact of Interspersed Transposable Elements in Cancer

  2021cites this paper
• A new founder BRCA1 haplotype identified in the Puglia region is associated with a specific age-related cancer onset in three unrelated families

  2020cites this paper
• Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing

  2020cites this paper
• Droplet Digital PCR for Large Genomic Rearrangements detection: a promising strategy in tissue BRCA1 testing.

  2020cites this paper
• Promising member of the short interspersed nuclear elements (Alu elements): mechanisms and clinical applications in human cancers

  2019cites this paper
• Detection of BRCA1/2 large genomic rearrangements in breast and ovarian cancer patients: an overview of the current methods

  2019cites this paper
• A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis

  2018cites this paper
• Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients

  2018cites this paper
• A comprehensive BRCA1/2 NGS pipeline for an immediate Copy Number Variation (CNV) detection in breast and ovarian cancer molecular diagnosis.

  2018cites this paper
• Single-strand annealing between inverted DNA repeats: Pathway choice, participating proteins, and genome destabilizing consequences

  2018cites this paper
• DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes

  2018cites this paper
• BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study

  2018cites this paper
• Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

  2018cites this paper